Grégoire Berthod

700 total citations
24 papers, 433 citations indexed

About

Grégoire Berthod is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Grégoire Berthod has authored 24 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Grégoire Berthod's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Melanoma and MAPK Pathways (5 papers). Grégoire Berthod is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers) and Melanoma and MAPK Pathways (5 papers). Grégoire Berthod collaborates with scholars based in Switzerland, United States and Australia. Grégoire Berthod's co-authors include Olivier Michielin, Daniel E. Speiser, Solange Peters, Emanuela Romano, Igor Letovanec, Jesica Mazza‐Stalder, Romain Lazor, Immanuel F. Luescher, Nathalie Rufer and Philippe Guillaume and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Grégoire Berthod

19 papers receiving 428 citations

Peers

Grégoire Berthod
Ming-Tseh Lin United States
Karmela K Chan United States
Chunju Zhou China
Line Ohm‐Laursen Denmark
Maria Velegraki Greece
Ornella Carminati Italy
Kieran Adam United States
Alessandra Jales United States
Haruhi Takagi Japan
Jaydeep Bhat Germany
Ming-Tseh Lin United States
Grégoire Berthod
Citations per year, relative to Grégoire Berthod Grégoire Berthod (= 1×) peers Ming-Tseh Lin

Countries citing papers authored by Grégoire Berthod

Since Specialization
Citations

This map shows the geographic impact of Grégoire Berthod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégoire Berthod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégoire Berthod more than expected).

Fields of papers citing papers by Grégoire Berthod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grégoire Berthod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégoire Berthod. The network helps show where Grégoire Berthod may publish in the future.

Co-authorship network of co-authors of Grégoire Berthod

This figure shows the co-authorship network connecting the top 25 collaborators of Grégoire Berthod. A scholar is included among the top collaborators of Grégoire Berthod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grégoire Berthod. Grégoire Berthod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florea, Cristina, et al.. (2025). Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy. Case Reports in Oncology. 18(1). 1171–1177.
2.
Charrier, Mélinda, et al.. (2025). Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy. Cancers. 17(14). 2370–2370. 1 indexed citations
3.
Dong, Catherine, et al.. (2024). Severe Colitis in 2 Patients with Melanoma Treated with BRAF/MEK Inhibitors: Case Report and Literature Review. SHILAP Revista de lepidopterología. 17(1). 191–201.
4.
Gérard, Camille L., Sarah Boughdad, Grégoire Berthod, et al.. (2022). Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma. Cancers. 14(5). 1162–1162. 12 indexed citations
5.
Gérard, Camille L., Alexandre Wicky, Grégoire Berthod, et al.. (2021). Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients.. Journal of Clinical Oncology. 39(15_suppl). e21529–e21529. 1 indexed citations
6.
Dunet, Vincent, Andreas F. Hottinger, Grégoire Berthod, et al.. (2019). Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient. Journal for ImmunoTherapy of Cancer. 7(1). 336–336. 17 indexed citations
7.
Homicskó, Krisztián, David Barras, Grégoire Berthod, et al.. (2019). Unsorted single-cell RNA sequencing profiles of metastatic melanoma patients reveal the heterogeneity of melanoma-associated fibroblasts. Annals of Oncology. 30. v536–v536. 1 indexed citations
8.
Berthod, Grégoire, et al.. (2016). Diarrhées provoquées par les traitements systémiques anticancéreux. Revue Médicale Suisse. 12(529). 1462–1467. 1 indexed citations
9.
Berthod, Grégoire, et al.. (2016). [Diarrhea caused by systemic anti-cancer treatments].. PubMed. 12(529). 1462–1467.
10.
Legat, Amandine, Hélène Maby–El Hajjami, Petra Baumgaertner, et al.. (2015). Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial. Clinical Cancer Research. 22(6). 1330–1340. 76 indexed citations
11.
12.
Gerö, Dániel, Ariane Boubaker, Grégoire Berthod, et al.. (2014). Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease. Melanoma Research. 24(4). 371–376. 2 indexed citations
13.
Hitz, Felicitas, Natalie Fischer, Clemens B. Caspar, et al.. (2013). Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial. Annals of Hematology. 92(8). 1033–1040. 18 indexed citations
14.
Berthod, Grégoire, Romain Lazor, Igor Letovanec, et al.. (2012). Pulmonary Sarcoid-Like Granulomatosis Induced by Ipilimumab. Journal of Clinical Oncology. 30(17). e156–e159. 135 indexed citations
15.
Jandus, Camilla, Jean‐Paul Rivals, Laurent Derré, et al.. (2011). Vaccination‐induced functional competence of circulating human tumor‐specific CD8 T‐cells. International Journal of Cancer. 130(11). 2607–2617. 43 indexed citations
16.
Zaman, Khalil, Beat Thürlimann, Jens Huober, et al.. (2011). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of Oncology. 23(6). 1474–1481. 32 indexed citations
17.
Berthod, Grégoire, Krisztián Homicskó, Hasna Bouchaab, et al.. (2011). [Melanoma: a new therapeutic era].. PubMed. 7(296). 1126–30.
18.
Berthod, Grégoire, et al.. (2010). Solitary Choriocarcinoma in the Lung. Journal of Thoracic Oncology. 5(4). 574–575. 13 indexed citations
19.
Dahmane, Elyes, Chantal Csajka, Lucien Perey, et al.. (2010). Abstract PD05-09: Prospective Assessment of CYP2D6 by Genotyping, Phenotyping and Measurement of Tamoxifen, 4-Hydroxy-Tamoxifen and Endoxifen in Breast Cancer Patients Treated with Tamoxifen. Cancer Research. 70(24_Supplement). PD05–9. 1 indexed citations
20.
Berthod, Grégoire, et al.. (2007). Dénutrition : quelles stratégies pour une pathologie que l’on ne peut plus négliger à l’hôpital ?. Revue Médicale Suisse. 3(131). 2466–2471.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming-Tseh Lin Breakdown of academic impact, for papers by Karmela K Chan Breakdown of academic impact, for papers by Chunju Zhou Breakdown of academic impact, for papers by Line Ohm‐Laursen Breakdown of academic impact, for papers by Maria Velegraki Breakdown of academic impact, for papers by Ornella Carminati Breakdown of academic impact, for papers by Kieran Adam Breakdown of academic impact, for papers by Alessandra Jales Breakdown of academic impact, for papers by Haruhi Takagi Breakdown of academic impact, for papers by Jaydeep Bhat
Rankless by CCL
2026